Jiangsu Nhwa Pharmaceutical Co., LTD

¥22.87As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002262Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 8.01%
Div yield 1.75%
ROE 13.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.25)
PE TTM 20.84
TSR TTM (7.34%)
Mkt cap ¥23.17B
ROIC 22.30%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
(1.06%)
(54.20%)
Hold 3|9|7|4|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.55
0.55
0.61
0.60
24.22%
14.51%
22.54%
18.74%
Revenue¥B
1.068
1.115
1.092
1.155
1.10%
8.14%
3.34%
6.76%
Peers (US$3.473B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.282
0.078
0.077
EBIT/Intx
0.876
0.115
0.113
Own earn%
67.63
(5.62)
(11.43)
Sh yield%
33.72
22.29
26.33
Owners
Insiders/Inst%
6.38
68.12
Short interest%
3.00
SBC / revenue%
2.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
14–21
$1 testx
0.0
Incr. ROIC%
3